To ask the Secretary of State for Health and Social Care, what discussions officials in his Department have had with (a) sponsors of the University of Oxford's Recovery trial and (b) suppliers of each medication being used in that trial to ensure that adequate supplies of those medications are in place to treat covid-19 patients in the event that the trial has positive results.
Officials in the Department have regular conversations with the RECOVERY trial leads about the trial and central supply of medicines to the trial.
Teams in the Department, Public Health England, the Medicines and Healthcare products Regulatory Agency and NHS England and NHS Improvement also have daily discussions with suppliers and manufacturers of medicines, including about supplies to support clinical trials. In addition, the Department has been securing additional supplies of a number of medicines, which would ensure sufficient stocks are available to be rapidly deployed for National Health Service patients, should clinical trial evidence show it to be safe and effective to do so. The Department continues to review supply requirements as further clinical evidence becomes available.